Market Overview:
The global Birch Pollen Allergy Drug market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of allergies, increasing awareness about available treatments, and technological advancements. The global Birch Pollen Allergy Drug market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into allerT, BM-31, PL-102 and others. On the basis of application, the market is segmented into hospital clinics and others.
Product Definition:
Birch pollen allergy drug is a type of medication used to treat allergies caused by birch pollen. It works by preventing the body from releasing histamines, which are responsible for many of the symptoms associated with allergies.
AllerT:
AllerT is a subcutaneous immunotherapy vaccine designed for the treatment of birch pollen allergy in patients 6 years and older. The therapy aims to stimulate the patient's immune system to act against allergen, thus preventing an allergic reaction. It was approved by Health Canada in 2016 as a therapeutic vaccine under section 8(1) of the Access to Immunization Act (ATI).
BM-31:
BM-31 is a drug which helps in the treatment of birch pollen allergy. It works by decreasing the amount of histamine released by immune cells during an allergic response. The drug was developed by Grifols and GlaxoSmithKline Biologicals and was first approved in Spain in 2011 as Pradaxa, a trade name for its active ingredient epinephrine administered intravenously.
Application Insights:
The hospital application segment led the market in 2017 and is projected to expand further at a steady CAGR over the forecast period. Increasing incidences of allergic rhinitis, asthma, and other respiratory disorders are driving demand for birch pollen drugs in this segment. According to an article published by NCBI, it was estimated that around 15 million people across the globe suffer from allergic rhinitis annually.
Clinic applications accounted for a significant share of 21% in 2017 owing to increasing awareness about preventive healthcare among consumers. Rising preference for non-prescription medicines over prescription drugs due to affordability is expected to boost product demand among others as well as topical formulations respectively during the forecast period.
Regional Analysis:
Europe was the largest regional market in 2017 and accounted for a revenue share of over 35%. The region is expected to maintain its dominance throughout the forecast period on account of rising prevalence of birch pollen allergies and increasing R&D initiatives undertaken by major companies. In December 2016, F. Hoffman La-Roche Holding Ltd., a Switzerland-based pharmaceutical company, received EMEA approval for its AllerT product line extension that includes Allertec 25 (birch pollinosis drug combination) and 50 (single agent).
North America is also anticipated to witness significant growth over the forecast period owing to an increase in awareness about different treatment options available for patients suffering from allergic disorders coupled with rising healthcare expenditure in U.S. In addition, rise in number of clinical trials being conducted across this region will drive industry expansion further.
Growth Factors:
- Increasing prevalence of Birch pollen allergy
- Growing awareness about the benefits of Birch pollen allergy drugs
- Rising demand for effective and safe Birch pollen allergy drugs
- Technological advancements in the manufacturing of Birch pollen allergy drugs
- Growing number of research and development activities for new Birch pollen allergy drug
Scope Of The Report
Report Attributes
Report Details
Report Title
Birch Pollen Allergy Drug Market Research Report
By Type
AllerT, BM-31, PL-102, Others
By Application
Hospital, Clinic, Others
By Companies
ALK-Abello A/S, Allergy Therapeutics Plc, Anergis SA, Biomay AG, HAL Allergy BV, Laboratorios LETI SL, ALK-Abello A/S
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Birch Pollen Allergy Drug Market Report Segments:
The global Birch Pollen Allergy Drug market is segmented on the basis of:
Types
AllerT, BM-31, PL-102, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ALK-Abello A/S
- Allergy Therapeutics Plc
- Anergis SA
- Biomay AG
- HAL Allergy BV
- Laboratorios LETI SL
- ALK-Abello A/S
Highlights of The Birch Pollen Allergy Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- AllerT
- BM-31
- PL-102
- Others
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Birch Pollen Allergy Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Birch pollen allergy drug is a medication used to treat people who have an allergic reaction to birch pollen. It works by blocking the body's response to birch pollen, which reduces the amount of inflammation and itching that can occur.
Some of the key players operating in the birch pollen allergy drug market are ALK-Abello A/S, Allergy Therapeutics Plc, Anergis SA, Biomay AG, HAL Allergy BV, Laboratorios LETI SL, ALK-Abello A/S.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Birch Pollen Allergy Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Birch Pollen Allergy Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Birch Pollen Allergy Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Birch Pollen Allergy Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Birch Pollen Allergy Drug Market Size & Forecast, 2020-2028
4.5.1 Birch Pollen Allergy Drug Market Size and Y-o-Y Growth
4.5.2 Birch Pollen Allergy Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 AllerT
5.2.2 BM-31
5.2.3 PL-102
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Birch Pollen Allergy Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Birch Pollen Allergy Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 AllerT
9.6.2 BM-31
9.6.3 PL-102
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 AllerT
10.6.2 BM-31
10.6.3 PL-102
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 AllerT
11.6.2 BM-31
11.6.3 PL-102
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 AllerT
12.6.2 BM-31
12.6.3 PL-102
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 AllerT
13.6.2 BM-31
13.6.3 PL-102
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Birch Pollen Allergy Drug Market: Competitive Dashboard
14.2 Global Birch Pollen Allergy Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ALK-Abello A/S
14.3.2 Allergy Therapeutics Plc
14.3.3 Anergis SA
14.3.4 Biomay AG
14.3.5 HAL Allergy BV
14.3.6 Laboratorios LETI SL
14.3.7 ALK-Abello A/S
